Related Experiment Video
Updated: Jun 20, 2026

Isolation and Culture of Cells from the Nephrogenic Zone of the Embryonic Mouse Kidney
Published on: April 22, 2011
p53 regulates metanephric development
Zubaida Saifudeen1, Susana Dipp, Jana Stefkova
1Section of Pediatric Nephrology, Department of Pediatrics, and the Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, LA 70112, USA. zubisaif@tulane.edu
Abstract:
p53 is best known as a tumor suppressor that regulates cell-cycle, differentiation, and apoptosis pathways, but its potential role in embryonic development and organogenesis remains controversial. Here, p53(-/-) embryos bred on C57Bl6 background exhibited a spectrum of congenital abnormalities of the kidney and urinary tract, including ureteric bud (UB) ectopia, double ureters/collecting systems, delayed primary branching of the UB, and hypoplastic metanephroi. We observed ectopic UB outgrowth from the Wolffian duct (WD) in one third of p53(-/-) embryos. The prevalence of duplex was higher in embryos than in neonates, and ex vivo organ culture suggested that ectopic ureters can regress over time, leaving behind a dysplastic pole ("segmental dysgenesis"). Transgenic expression of dominant negative p53 or conditional inactivation of p53 in the UB but not in the metanephric mesenchyme lineage recapitulated the duplex phenotype. Mechanistically, p53 inactivation in the WD associated with enhanced sensitivity to glial cell line-derived neurotrophic factor (GDNF)-induced ectopic budding and potentiated phosphatidylinositol-3 kinase activation by GDNF in UB cells. Unlike several other models of UB ectopia, hypersensitivity of p53(-/-) WD to GDNF is not accompanied by reduced Sprouty-1 or anterior expansion of the GDNF domain. In summary, our data lend support for a restrictive role for p53 activity in UB outgrowth from the WD.
Insights
The tumor suppressor p53 (protein 53) normally restricts ureteric bud (UB) outgrowth from the Wolffian duct (WD). Loss of p53 causes congenital kidney abnormalities, including ectopic UB budding.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- The tumor suppressor protein p53 (p53) is crucial for cell cycle regulation, differentiation, and apoptosis.
- Its role in embryonic development and organogenesis, particularly kidney development, is not fully understood.
Purpose of the Study:
- To investigate the role of p53 in embryonic kidney development and organogenesis.
- To elucidate the mechanisms by which p53 influences ureteric bud (UB) outgrowth and kidney formation.
Main Methods:
- Generation and analysis of p53 knockout (p53(-/-)) mouse embryos.
- Ex vivo organ culture of embryonic kidneys.
- Transgenic expression of dominant-negative p53 and conditional inactivation of p53 in specific cell lineages (UB and metanephric mesenchyme).
- Analysis of signaling pathways, including glial cell line-derived neurotrophic factor (GDNF) and phosphatidylinositol-3 kinase (PI3K).
Main Results:
- p53(-/-) embryos display a range of congenital kidney and urinary tract abnormalities, including ureteric bud ectopia, duplex systems, and hypoplastic kidneys.
- Ectopic UB outgrowth from the Wolffian duct (WD) was observed in a significant portion of p53(-/-) embryos.
- Conditional inactivation of p53 in the UB, but not the metanephric mesenchyme, recapitulated the duplex phenotype.
- p53 inactivation in the WD leads to enhanced sensitivity to GDNF-induced ectopic budding and potentiated PI3K activation by GDNF.
Conclusions:
- p53 plays a critical restrictive role in regulating ureteric bud outgrowth from the Wolffian duct during kidney development.
- Loss of p53 function results in aberrant UB budding, leading to congenital abnormalities of the kidney and urinary tract.
- The findings highlight a novel function of p53 in preventing ectopic UB development mediated by GDNF signaling.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators